Intrinsic Value of S&P & Nasdaq Contact Us

Bellicum Pharmaceuticals, Inc. BLCM NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
47/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Bellicum Pharmaceuticals, Inc. (BLCM) has 20 known insider and institutional holders on record. The largest holder is Fair Richard A. with 400,000 shares. Other notable holders include Scripture Charity and Stonehouse Jon P.

BLCM Insider Ownership

Top Holder
Fair Richard A.
400,000 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Fair Richard A. President and CEO 400,000 2022-08-16
100%
2 Scripture Charity Chief Development Officer 250,000 2022-08-16
63%
3 Stonehouse Jon P Director 204,086 2023-01-05
51%
4 Baker Bros. Advisors Lp 10 Percent Owner 196,654 2023-11-24
49%
5 Huber Reid M Director 146,951 2023-01-20
37%
6 Davis Stephen Director 136,854 2023-01-05
34%
7 Klimovsky Judith V Director 110,098 2023-01-05
28%
8 Daly James M Director 109,873 2023-01-05
27%
9 Musso Alan A CFO and Treasurer 52,500 2018-07-05
13%
10 Strauss David Eric Sr Director, Corp Controller 35,000 2020-12-16
9%
11 Farrell Thomas J. President and CEO 26,875 2017-01-05
7%
12 Grossman William Sr. VP, Chief Medical Officer 26,874 2019-02-07
7%
13 Harrigan Edmund Director 25,000 2019-06-14
6%
14 Smith Alan K. EVP, Technical Operations 22,307 2020-04-09
6%
15 Mokari Atabak Chief Financial Officer 21,792 2020-04-09
5%
16 Senesac Joseph VP of Manufacturing 20,000 2015-02-26
5%
17 Foster Aaron E. Sr VP, Head of Research 19,517 2020-04-09
5%
18 Spencer David M. Chief Technology Officer 15,000 2019-02-05
4%
19 Naeve Gregory S. Chief Business Officer 13,746 2019-08-23
3%
20 Slawin Kevin M. Director 10,000 2017-06-15
3%

No ownership data available for BLCM.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message